Roles of the picornaviral 3c proteinase in the viral life cycle and host cells

Viruses

Volumn 8, Issue 3, 2016, Pages

  Sun, Di ^a   Chen, Shun ^a,b   Cheng, Anchun ^a,b   Wang, Mingshu ^a,b  

^a SICHUAN AGRICULTURAL UNIVERSITY   (China)

^b KEY LABORATORY OF ANIMAL DISEASE AND HUMAN HEALTH OF SICHUAN PROVINCE   (China)

Author keywords

3Cpro; Pathogenesis; Protease inhibitor; Structure; Translation initiation; Viral replication

Indexed keywords

3C LIKE PROTEASE; 3C PROTEINASE; MICROTUBULE ASSOCIATED PROTEIN 4; POLYPROTEIN; PROTEINASE; UNCLASSIFIED DRUG; 3C PROTEASES; ANTIVIRUS AGENT; CYSTEINE PROTEINASE; ENZYME INHIBITOR; PROTEIN BINDING; VIRAL PROTEIN; VIRUS RNA;

ARTICLE; CELL DEATH; GOLGI COMPLEX; HOST CELL; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; IMMUNITY; LIFE CYCLE; PICORNAVIRIDAE; PROTEIN DEGRADATION; RNA REPLICATION; RNA SYNTHESIS; VIRUS PATHOGENESIS; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; CHEMISTRY; CONSERVED SEQUENCE; DRUG DEVELOPMENT; ENZYMOLOGY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; PROTEIN PROCESSING; TRENDS;

ANTIVIRAL AGENTS; CONSERVED SEQUENCE; CYSTEINE ENDOPEPTIDASES; DRUG DISCOVERY; ENZYME INHIBITORS; HOST-PATHOGEN INTERACTIONS; HUMANS; PICORNAVIRIDAE; POLYPROTEINS; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, VIRAL; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84961237766     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8030082     Document Type: Article

References (151)

1. Adams, M.J.; King, A.M.Q.; Carstens, E.B. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2013). Arch. Virol. 2013, 158, 2023-2030
2. King, A.M.Q.; Adams, M.J.; Carstens, E.B.; Lefkowitz, E.J. Virus Taxonomy: Classification and Nomenclature of Viruses: Ninth Report of the International Committee on Taxonomy of Viruses; Academic Press/Elsevier: London, UK, 2012; pp. 855-880.
3. Lewis, S.A.; Morgan, D.O.; Grubman, M.J. Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: Induction of a neutralizing antibody response in guinea pigs. J. Virol. 1991, 65, 6572-6580
4. Khan, A.; Sharif, S.; Shaukat, S.; Khan, S.; Zaidi, S. An outbreak of acute hemorrhagic conjunctivitis (AHC) caused by coxsackievirus A24 variant in pakistan. Virus Res. 2008, 137, 150-152
5. Sapkal, G.N.; Bondre, V.P.; Fulmali, P.V.; Patil, P.; Gopalkrishna, V.; Dadhania, V.; Ayachit, V.M.; Gangale, D.; Kushwaha, K.P.; Rathi, A.K.; et al. Enteroviruses in patients with acute encephalitis, Uttar Pradesh, India. Emerg. Infect. Dis. 2009, 15, 295-298
6. Zhang, Y.; Tan, X.J.; Wang, H.Y.; Yan, D.M.; Zhu, S.L.; Wang, D.Y.; Ji, F.; Wang, X.J.; Gao, Y.J.; Chen, L.; et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J. Clin. Virol. 2009, 44, 262-267
7. Hayden, F.G.; Turner, R.B.; Gwaltney, J.M.; Chi-Burris, K.; Gersten, M.; Hsyu, P.; Patick, A.K.; Smith, G.J.; Zalman, L.S. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob. Agents Chemother. 2003, 47, 3907-3916
8. Patick, A.K. Rhinovirus chemotherapy. Antiviral Res. 2006, 71, 391-396
9. Paul, A.V.; Rieder, E.; Kim, D.W.; van Boom, J.H.; Wimmer, E. Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J. Virol. 2000, 74, 10359-10370
10. Birtley, J.R.; Knox, S.R.; Jaulent, A.M.; Brick, P.; Leatherbarrow, R.J.; Curry, S. Crystal structure of foot-and-mouth disease virus 3C protease. New insights into catalytic mechanism and cleavage specificity. J. Biol. Chem. 2005, 280, 11520-11527
11. Bergmann, E.M.; Cherney, M.M.; McKendrick, J.; Frormann, S.; Luo, C.; Malcolm, B.A.; Vederas, J.C.; James, M.N. Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotein processing in HAV. Virology 1999, 265, 153-163
12. Mosimann, S.C.; Cherney, M.M.; Sia, S.; Plotch, S.; James, M.N. Refined X-ray crystallographic structure of the poliovirus 3C gene product. J. Mol. Biol. 1997, 273, 1032-1047
13. Matthews, D.A.; Smith, W.W.; Ferre, R.A.; Condon, B.; Budahazi, G.; Sisson, W.; Villafranca, J.E.; Janson, C.A.; McElroy, H.E.; Gribskov, C.L.; et al. Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell 1994, 77, 761-771
14. Matthews, D.A.; Dragovich, P.S.; Webber, S.E.; Fuhrman, S.A.; Patick, A.K.; Zalman, L.S.; Hendrickson, T.F.; Love, R.A.; Prins, T.J.; Marakovits, J.T.; et al. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc. Nalt. Acad. Sci. USA 1999, 96, 11000-11007
15. Yin, J.; Bergmann, E.M.; Cherney, M.M.; Lall, M.S.; Jain, R.P.; Vederas, J.C.; James, M.N. Dual modes of modification of hepatitis a virus 3C protease by a serine-derived β-lactone: Selective crystallization and formation of a functional catalytic triad in the active site. J. Mol. Biol. 2005, 354, 854-871
16. Sweeney, T.R.; Roqué-Rosell, N.; Birtley, J.R.; Leatherbarrow, R.J.; Curry, S. Structural and mutagenic analysis of foot-and-mouth disease virus 3C protease reveals the role of the β-ribbon in proteolysis. J. Virol. 2007, 81, 115-124
17. Cui, S.; Wang, J.; Fan, T.; Qin, B.; Guo, L.; Lei, X.; Wang, J.; Wang, M.; Jin, Q. Crystal structure of human enterovirus 71 3C protease. J. Mol. Biol. 2011, 408, 449-461
18. Bergmann, E.M.; Mosimann, S.C.; Chernaia, M.M.; Malcolm, B.A.; James, M.N. The refined crystal structure of the 3C gene product from hepatitis a virus: Specific proteinase activity and RNA recognition. J. Virol. 1997, 71, 2436-2448
19. Wang, J.; Fan, T.; Yao, X.; Wu, Z.; Guo, L.; Lei, X.; Wang, J.; Wang, M.; Jin, Q.; Cui, S. Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues. J. Virol. 2011, 85, 10021-10030
20. Curry, S.; Roqué-Rosell, N.; Zunszain, P.A.; Leatherbarrow, R.J. Foot-and-mouth disease virus 3C protease: Recent structural and functional insights into an antiviral target. Int. J. Biochem. Cell Biol. 2007, 39, 1-6
21. Seipelt, J.; Guarné, A.; Bergmann, E.; James, M.; Sommergruber, W.; Fita, I.; Skern, T. The structures of picornaviral proteinases. Virus Res. 1999, 62, 159-168
22. Guarné, A.; Hampoelz, B.; Glaser, W.; Carpena, X.; Tormo, J.; Fita, I.; Skern, T. Structural and biochemical features distinguish the foot-and-mouth disease virus leader proteinase from other papain-like enzymes. J. Mol. Biol. 2000, 302, 1227-1240
23. Salas, E.M.; Ryan, M.D. Translation and protein process. In The Picornaviruses; Ehrenfeld, E., Domingo, E., Roos, R., Eds.; ASM Press: Washington, DC, USA, 2010; pp. 141-150.
24. Palmenberg, A.; Neubauer, D.; Skern, T. Genome organization and encoded proteins. In The Picornaviruses; Ehrenfeld, E., Domingo, E., Roos, R., Eds.; ASM Press: Washington, DC, USA, 2010; pp. 3-17.
25. Castelló, A.; Alvarez, E.; Carrasco, L. The multifaceted poliovirus 2A protease: Regulation of gene expression by picornavirus proteases. J. Biomed. Biotechnol. 2011
26. Amineva, S.P.; Aminev, A.G.; Palmenberg, A.C.; Gern, J.E. Rhinovirus 3C protease precursors 3CD and 3CD1 localize to the nuclei of infected cells. J. Gen. Virol. 2004, 85, 2969-2979
27. Ryan, M.D.; Belsham, G.J.; King, A.M. Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing. Virology 1989, 173, 35-45
28. Ypma-Wong, M.F.; Dewalt, P.G.; Johnson, V.H.; Lamb, J.G.; Semler, B.L. Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor. Virology 1988, 166, 265-270
29. Guarné, A.; Tormo, J.; Kirchweger, R.; Pfistermueller, D.; Fita, I.; Skern, T. Structure of the foot-and-mouth disease virus leader protease: A papain-like fold adapted for self-processing and eIF4G recognition. EMBO J. 1998, 17, 7469-7479
30. Spear, A.; Ogram, S.A.; Morasco, B.J.; Smerage, L.E.; Flanegan, J.B. Viral precursor protein P3 and its processed products perform discrete and essential functions in the poliovirus RNA replication complex. Virology 2015, 485, 492-501
31. Yin, J.; Paul, A.V.; Wimmer, E.; Rieder, E. Functional dissection of a poliovirus cis-acting replication element (PV-cre(2C)): Analysis of single- and dualcre viral genomes and proteins that bind specifically to PV-cre RNA. J. Virol. 2003, 77, 5152-5166
32. Pathak, H.B.; Arnold, J.J.; Wiegand, P.N.; Hargittai, M.R.; Cameron, C.E. Picornavirus genome replication: Assembly and organization of the VPg uridylylation ribonucleoprotein (initiation) complex. J. Biol. Chem. 2007, 282, 16202-16213
33. Pathak, H.B.; Oh, H.S.; Goodfellow, I.G.; Arnold, J.J.; Cameron, C.E. Picornavirus genome replication: Roles of precursor proteins and rate-limiting steps in oriI-dependent VPg uridylylation. J. Biol. Chem. 2008, 283, 30677-30688
34. Kusov, Y.Y.; Morace, G.; Probst, C.; Gauss-Müller, V. Interaction of hepatitis A virus (HAV) precursor proteins 3AB and 3ABC with the 51 and 31 termini of the HAV RNA. Virus Res. 1997, 51, 151-157
35. Paul, A.V.; Wimmer, E. Initiation of protein-primed picornavirus RNA synthesis. Virus Res. 2015, 206, 12-26
36. Andino, R.; Rieckhof, G.E.; Trono, D.; Baltimore, D. Substitutions in the protease (3Cpro) gene of poliovirus can suppress a mutation in the 5’noncoding region. J. Virol. 1990, 64, 607-612
37. Andino, R.; Rieckhof, G.E.; Baltimore, D. A functional ribonucleoprotein complex forms around the 51 end of poliovirus RNA. Cell 1990, 63, 369-380
38. Andino, R.; Rieckhof, G.E.; Achacoso, P.L.; Baltimore, D. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5’-end of viral RNA. EMBO J. 1993, 12, 3587-3598
39. Nayak, A.; Goodfellow, I.G.; Belsham, G.J. Factors required for the uridylylation of the foot-and-mouth disease virus 3B1, 3B2, and 3B3 peptides by the RNA-dependent RNA polymerase (3Dpol) in vitro. J. Virol. 2005, 79, 7698-7706
40. Nayak, A.; Goodfellow, I.G.; Woolaway, K.E.; Birtley, J.; Curry, S.; Belsham, G.J. Role of RNA structure and RNA binding activity of foot-and-mouth disease virus 3C protein in VPg uridylylation and virus replication. J. Virol. 2006, 80, 9865-9875
41. Herold, J.; Andino, R. Poliovirus RNA replication requires genome circularization through a protein-protein bridge. Mol. Cell 2001, 7, 581-591
42. Harris, K.S.; Xiang, W.; Alexander, L.; Lane, W.S.; Paul, A.V.; Wimmer, E. Interaction of poliovirus polypeptide 3CDpro with the 5’and 3’termini of the poliovirus genome. Identification of viral and cellular cofactors needed for efficient binding. J. Biol. Chem. 1994, 269, 27004-27014
43. Franco, D.; Pathak, H.B.; Cameron, C.E.; Rombaut, B.; Wimmer, E.; Paul, A.V. Stimulation of poliovirus synthesis in a HeLa cell-free in vitro translation-RNA replication system by viral protein 3CDpro. J. Virol. 2005, 79, 6358-6367
44. Blair, W.S.; Parsley, T.B.; Bogerd, H.P.; Towner, J.S.; Semler, B.L.; Cullen, B.R. Utilization of a mammalian cell-based RNA binding assay to characterize the RNA binding properties of picornavirus 3C proteinases. RNA 1998, 4, 215-225
45. Moustafa, I.M.; Gohara, D.W.; Uchida, A.; Yennawar, N.; Cameron, C.E. Conformational ensemble of the poliovirus 3CD precursor observed by md simulations and confirmed by saxs: A strategy to expand the viral proteome? Viruses 2015, 7, 5962-5986
46. Gamarnik, A.V.; Andino, R. Switch from translation to RNA replication in a positive-stranded RNA virus. Genes Dev. 1998, 12, 2293-2304
47. Chase, A.J.; Daijogo, S.; Semler, B.L. Inhibition of poliovirus-induced cleavage of cellular protein PCBP2 reduces the levels of viral RNA replication. J. Virol. 2014, 88, 3192-3201
48. Chan, Y.M.; Boehr, D.D. Allosteric functional switch in poliovirus 3C protease. FASEB J. 2015, 29
49. Banerjee, R.; Weidman, M.K.; Navarro, S.; Comai, L.; Dasgupta, A. Modifications of both selectivity factor and upstream binding factor contribute to poliovirus-mediated inhibition of RNA polymerase I transcription. J. Gen. Virol. 2005, 86, 2315-2322
50. Kundu, P.; Raychaudhuri, S.; Tsai, W.; Dasgupta, A. Shutoff of RNA polymerase II transcription by poliovirus involves 3C protease-mediated cleavage of the TATA-binding protein at an alternative site: Incomplete shutoff of transcription interferes with efficient viral replication. J. Virol. 2005, 79, 9702-9713
51. Yalamanchili, P.; Datta, U.; Dasgupta, A. Inhibition of host cell transcription by poliovirus: Cleavage of transcription factor CREB by poliovirus-encoded protease 3Cpro. J. Virol. 1997, 71, 1220-1226
52. Yalamanchili, P.; Weidman, K.; Dasgupta, A. Cleavage of transcriptional activator Oct-1 by poliovirus encoded protease 3Cpro. Virology 1997, 239, 176-185
53. Weidman, M.K.; Yalamanchili, P.; Ng, B.; Tsai, W.; Dasgupta, A. Poliovirus 3C protease-mediated degradation of transcriptional activator p53 requires a cellular activity. Virology 2001, 291, 260-271
54. Shen, Y.; Igo, M.; Yalamanchili, P.; Berk, A.J.; Dasgupta, A. DNA binding domain and subunit interactions of transcription factor IIIC revealed by dissection with poliovirus 3C protease. Mol. Cell. Biol. 1996, 16, 4163-4171
55. Falk, M.M.; Grigera, P.R.; Bergmann, I.E.; Zibert, A.; Multhaup, G.; Beck, E. Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. J. Virol. 1990, 64, 748-756
56. Weng, K.F.; Li, M.L.; Hung, C.T.; Shih, S.R. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog. 2009, 5, e1000593
57. Sonenberg, N.; Hinnebusch, A.G. Regulation of translation initiation in eukaryotes: Mechanisms and biological targets. Cell 2009, 136, 731-745
58. Lozano, G.; Martínez-Salas, E. Structural insights into viral IRES-dependent translation mechanisms. Curr. Opin. Virol. 2015, 12, 113-120
59. Martínez-Salas, E.; Pacheco, A.; Serrano, P.; Fernandez, N. New insights into internal ribosome entry site elements relevant for viral gene expression. J. Gen. Virol. 2008, 89, 611-626
60. Martínez-Salas, E.; Francisco-Velilla, R.; Fernandez-Chamorro, J.; Lozano, G.; Diaz-Toledano, R. Picornavirus IRES elements: RNA structure and host protein interactions. Virus Res. 2015, 206, 62-73
61. Belsham, G.J.; McInerney, G.M.; Ross-Smith, N. Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells. J. Virol. 2000, 74, 272-280
62. Gradi, A.; Foeger, N.; Strong, R.; Svitkin, Y.V.; Sonenberg, N.; Skern, T.; Belsham, G.J. Cleavage of eukaryotic translation initiation factor 4GII within foot-and-mouth disease virus-infected cells: Identification of the L-protease cleavage site in vitro. J. Virol. 2004, 78, 3271-3278
63. Li, W.; Ross-Smith, N.; Proud, C.G.; Belsham, G.J. Cleavage of translation initiation factor 4AI (eIF4AI) but not eIF4AII by foot-and-mouth disease virus 3C protease: Identification of the eIF4AI cleavage site. FEBS Lett. 2001, 507, 1-5
64. De Breyne, S.; Bonderoff, J.M.; Chumakov, K.M.; Lloyd, R.E.; Hellen, C.U. Cleavage of eukaryotic initiation factor eIF5B by enterovirus 3C proteases. Virology 2008, 378, 118-122
65. Perera, R.; Daijogo, S.; Walter, B.L.; Nguyen, J.H.; Semler, B.L. Cellular protein modification by poliovirus: The two faces of poly (rC)-binding protein. J. Virol. 2007, 81, 8919-8932
66. Zhang, B.; Seitz, S.; Kusov, Y.; Zell, R.; Gauss-Müller, V. RNA interaction and cleavage of poly (C)-binding protein 2 by hepatitis A virus protease. Biochem. Biophys. Res. Commun. 2007, 364, 725-730
67. Kuyumcu-Martinez, N.M.; Van Eden, M.E.; Younan, P.; Lloyd, R.E. Cleavage of poly (A)-binding protein by poliovirus 3C protease inhibits host cell translation: A novel mechanism for host translation shutoff. Mol. Cell. Biol. 2004, 24, 1779-1790
68. Zhang, B.; Morace, G.; Gauss-Müller, V.; Kusov, Y. Poly(A) binding protein, C-terminally truncated by the hepatitis A virus proteinase 3C, inhibits viral translation. Nucleic Acids Res. 2007, 35, 5975-5984
69. Kobayashi, M.; Arias, C.; Garabedian, A.; Palmenberg, A.C.; Mohr, I. Site-specific cleavage of the host poly (A) binding protein by the encephalomyocarditis virus 3C proteinase stimulates viral replication. J. Virol. 2012, 86, 10686-10694
70. Fung, G.; Ng, C.S.; Zhang, J.; Shi, J.; Wong, J.; Piesik, P.; Han, L.; Chu, F.; Jagdeo, J.; Jan, E.; et al. Production of a dominant-negative fragment due to G3BP1 cleavage contributes to the disruption of mitochondria-associated protective stress granules during CVB3 infection. PLoS ONE 2013, 8, e79546
71. Lawrence, P.; Schafer, E.A.; Rieder, E. The nuclear protein Sam68 is cleaved by the FMDV 3C protease redistributing Sam68 to the cytoplasm during FMDV infection of host cells. Virology 2012, 425, 40-52
72. Flather, D.; Semler, B.L. Picornaviruses and nuclear functions: Targeting a cellular compartment distinct from the replication site of a positive-strand RNA virus. Front. Microbiol. 2015, 6, 594
73. Watters, K.; Palmenberg, A.C. Differential processing of nuclear pore complex proteins by rhinovirus 2A proteases from different species and serotypes. J. Virol. 2011, 85, 10874-10883
74. Walker, E.J.; Younessi, P.; Fulcher, A.J.; McCuaig, R.; Thomas, B.J.; Bardin, P.G.; Jans, D.A.; Ghildyal, R. Rhinovirus 3C protease facilitates specific nucleoporin cleavage and mislocalisation of nuclear proteins in infected host cells. PLoS ONE 2013, 8, e71316
75. Caly, L.; Ghildyal, R.; Jans, D.A. Respiratory virus modulation of host nucleocytoplasmic transport; target for therapeutic intervention? Front. Microbiol. 2015, 6, 848
76. Park, N.; Katikaneni, P.; Skern, T.; Gustin, K.E. Differential targeting of nuclear pore complex proteins in poliovirus-infected cells. J. Virol. 2008, 82, 1647-1655
77. Park, N.; Skern, T.; Gustin, K.E. Specific cleavage of the nuclear pore complex protein Nup62 by a viral protease. J. Biol. Chem. 2010, 285, 28796-28805
78. Ghildyal, R.; Jordan, B.; Li, D.; Dagher, H.; Bardin, P.G.; Gern, J.E.; Jans, D.A. Rhinovirus 3C protease can localize in the nucleus and alter active and passive nucleocytoplasmic transport. J. Virol. 2009, 83, 7349-7352
79. Alber, F.; Dokudovskaya, S.; Veenhoff, L.M.; Zhang, W.; Kipper, J.; Devos, D.; Suprapto, A.; Karni-Schmidt, O.; Williams, R.; Chait, B.T. The molecular architecture of the nuclear pore complex. Nature 2007, 450, 695-701
80. Grossman, E.; Medalia, O.; Zwerger, M. Functional architecture of the nuclear pore complex. Annu. Rev. Biophys. 2012, 41, 557-584
81. Porter, F.W.; Palmenberg, A.C. Leader-induced phosphorylation of nucleoporins correlates with nuclear trafficking inhibition by cardioviruses. J. Virol. 2009, 83, 1941-1951
82. Ricour, C.; Delhaye, S.; Hato, S.V.; Olenyik, T.D.; Michel, B.; van Kuppeveld, F.J.; Gustin, K.E.; Michiels, T. Inhibition of mrna export and dimerization of interferon regulatory factor 3 by theiler’s virus leader protein. J. Gen. Virol. 2009, 90, 177-186
83. Barco, A.; Feduchi, E.; Carrasco, L. Poliovirus protease 3Cpro kills cells by apoptosis. Virology 2000, 266, 352-360
84. Li, M.L.; Hsu, T.A.; Chen, T.C.; Chang, S.C.; Lee, J.C.; Chen, C.C.; Stollar, V.; Shih, S.R. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 2002, 293, 386-395
85. Chau, D.H.; Yuan, J.; Zhang, H.; Cheung, P.; Lim, T.; Liu, Z.; Sall, A.; Yang, D. Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. Apoptosis 2007, 12, 513-524
86. Shubin, A.V.; Demidyuk, I.V.; Lunina, N.A.; Komissarov, A.A.; Roschina, M.P.; Leonova, O.G.; Kostrov, S.V. Protease 3C of hepatitis A virus induces vacuolization of lysosomal/endosomal organelles and caspase-independent cell death. BMC Cell Biol. 2015, 16, 4
87. Amero, C.D.; Arnold, J.J.; Moustafa, I.M.; Cameron, C.E.; Foster, M.P. Identification of the oriI-binding site of poliovirus 3C protein by nuclear magnetic resonance spectroscopy. J. Virol. 2008, 82, 4363-4370
88. Joachims, M.; Harris, K.S.; Etchison, D. Poliovirus protease 3C mediates cleavage of microtubule-associated protein 4. Virology 1995, 211, 451-461
89. Zhou, Z.; Mogensen, M.M.; Powell, P.P.; Curry, S.; Wileman, T. Foot-and-mouth disease virus 3C protease induces fragmentation of the Golgi compartment and blocks intra-Golgi transport. J. Virol. 2013, 87, 11721-11729
90. Takeda, K.; Akira, S. Toll-like receptors in innate immunity. Int. Immunol. 2005, 17, 1-14
91. Deretic, V. Autophagy: An emerging immunological paradigm. J. Immunol. 2012, 189, 15-20
92. Pålsson-McDermott, E.M.; O’Neill, L.A. Building an immune system from nine domains. Biochem. Soc. Trans. 2007, 35, 1437-1444
93. Akira, S.; Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4, 499-511
94. Bowie, A.; O’neill, L.A. The interleukin-1 receptor/toll-like receptor superfamily: Signal generators for pro-inflammatory interleukins and microbial products. J. Leukoc. Biol. 2000, 67, 508-514
95. Kawai, T.; Akira, S. Innate immune recognition of viral infection. Nat. Immunol. 2006, 7, 131-137
96. Oganesyan, G.; Saha, S.K.; Guo, B.; He, J.Q.; Shahangian, A.; Zarnegar, B.; Perry, A.; Cheng, G. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 2006, 439, 208-211
97. Häcker, H.; Redecke, V.; Blagoev, B.; Kratchmarova, I.; Hsu, L.C.; Wang, G.G.; Kamps, M.P.; Raz, E.; Wagner, H.; Häcker, G.; et al. Specificity in toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 2006, 439, 204-207
98. Sharma, S.; tenOever, B.R.; Grandvaux, N.; Zhou, G.P.; Lin, R.; Hiscott, J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003, 300, 1148-1151
99. Oshiumi, H.; Matsumoto, M.; Funami, K.; Akazawa, T.; Seya, T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 2003, 4, 161-167
100. Fitzgerald, K.A.; McWhirter, S.M.; Faia, K.L.; Rowe, D.C.; Latz, E.; Golenbock, D.T.; Coyle, A.J.; Liao, S.M.; Maniatis, T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003, 4, 491-496
101. Arpaia, N.; Barton, G.M. Toll-like receptors: Key players in antiviral immunity. Curr. Opin. Virol. 2011, 1, 447-454
102. Lei, X.; Liu, X.; Ma, Y.; Sun, Z.; Yang, Y.; Jin, Q.; He, B.; Wang, J. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 2010, 84, 8051-8061
103. Wang, B.; Xi, X.; Lei, X.; Zhang, X.; Cui, S.; Wang, J.; Jin, Q.; Zhao, Z. Enterovirus 71 protease 2A pro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathol. 2013, 9, e1003231
104. Lei, X.; Sun, Z.; Liu, X.; Jin, Q.; He, B.; Wang, J. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by toll-like receptor 3. J. Virol. 2011, 85, 8811-8818
105. Papon, L.; Oteiza, A.; Imaizumi, T.; Kato, H.; Brocchi, E.; Lawson, T.G.; Akira, S.; Mechti, N. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology 2009, 393, 311-318
106. Barral, P.M.; Morrison, J.M.; Drahos, J.; Gupta, P.; Sarkar, D.; Fisher, P.B.; Racaniello, V.R. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 2007, 81, 3677-3684
107. Huang, H.I.; Weng, K.F.; Shih, S.R. Viral and host factors that contribute to pathogenicity of enterovirus 71. Future Microbiol. 2012, 7, 467-479
108. Lei, X.; Xiao, X.; Xue, Q.; Jin, Q.; He, B.; Wang, J. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J. Virol. 2013, 87, 1690-1698
109. Lei, X.; Han, N.; Xiao, X.; Jin, Q.; He, B.; Wang, J. Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex. J. Virol. 2014, 88, 9830-9841
110. Liu, Y.; Zhang, Z.; Zhao, X.; Yu, R.; Zhang, X.; Wu, S.; Liu, J.; Chi, X.; Song, X.; Fu, L.; et al. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating jak1 protein expression. Viral Immunol. 2014, 27, 267-276
111. Zhang, Y.; Mao, D.; Roswit, W.T.; Jin, X.; Patel, A.C.; Patel, D.A.; Agapov, E.; Wang, Z.; Tidwell, R.M.; Atkinson, J.J.; et al. PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection. Nat. Immunol. 2015, 16, 1215-1227
112. Yang, Y.; Liang, Y.; Qu, L.; Chen, Z.; Yi, M.; Li, K.; Lemon, S.M. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl. Acad. Sci. USA 2007, 104, 7253-7258
113. Qu, L. Evasion of RIG-I/MDA5 and TLR3-Mediated Innate Immunity by Hepatitis A Virus. Ph.D. Thesis, University of Texas Medical Branch, Galveston, TX, USA, 2010.
114. Qu, L.; Feng, Z.; Yamane, D.; Liang, Y.; Lanford, R.E.; Li, K.; Lemon, S.M. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathog. 2011, 7, e1002169
115. Wang, D.; Fang, L.; Wei, D.; Zhang, H.; Luo, R.; Chen, H.; Li, K.; Xiao, S. Hepatitis A virus 3C protease cleaves NEMO to impair induction of β interferon. J. Virol. 2014, 88, 10252-10258
116. Wang, D.; Fang, L.; Li, K.; Zhong, H.; Fan, J.; Ouyang, C.; Zhang, H.; Duan, E.; Luo, R.; Zhang, Z.; et al. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling. J. Virol. 2012, 86, 9311-9322
117. De Los Santos, T.; Diaz-San Segundo, F.; Grubman, M.J. Degradation of nuclear factor κB during foot-and-mouth disease virus infection. J. Virol. 2007, 81, 12803-12815
118. Wang, D.; Fang, L.; Luo, R.; Ye, R.; Fang, Y.; Xie, L.; Chen, H.; Xiao, S. Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels. Biochem. Biophys. Res. Commun. 2010, 399, 72-78
119. Du, Y.; Bi, J.; Liu, J.; Liu, X.; Wu, X.; Jiang, P.; Yoo, D.; Zhang, Y.; Wu, J.; Wan, R.; et al. 3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation. J. Virol. 2014, 88, 4908-4920
120. Mukherjee, A.; Morosky, S.A.; Delorme-Axford, E.; Dybdahl-Sissoko, N.; Oberste, M.S.; Wang, T.; Coyne, C.B. The Coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 2011, 7, e1001311
121. Xu, C.; He, X.; Zheng, Z.; Zhang, Z.; Wei, C.; Guan, K.; Hou, L.; Zhang, B.; Zhu, L.; Cao, Y.; et al. Downregulation of MicroRNA miR-526a by enterovirus inhibits RIG-I-Dependent innate immune response. J. Virol. 2014, 88, 11356-11368
122. Sreedharan, J.; Blair, I.P.; Tripathi, V.B.; Hu, X.; Vance, C.; Rogelj, B.; Ackerley, S.; Durnall, J.C.; Williams, K.L.; Buratti, E.; et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319, 1668-1672
123. Fung, G.; Shi, J.; Deng, H.; Hou, J.; Wang, C.; Hong, A.; Zhang, J.; Jia, W.; Luo, H. Cytoplasmic translocation, aggregation, and cleavage of TDP-43 by enteroviral proteases modulate viral pathogenesis. Cell Death Differ. 2015, 22, 2087-2097
124. Dragovich, P.S.; Zhou, R.; Webber, S.E.; Prins, T.J.; Kwok, A.K.; Okano, K.; Fuhrman, S.A.; Zalman, L.S.; Maldonado, F.C.; Brown, E.L.; et al. Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors. Bioorg. Med. Chem. Lett. 2000, 10, 45-48
125. Shepherd, T.A.; Cox, G.A.; McKinney, E.; Tang, J.; Wakulchik, M.; Zimmerman, R.E.; Villarreal, E.C. Small peptidic aldehyde inhibitors of human rhinovirus 3C protease. Bioorg. Med. Chem. Lett. 1996, 6, 2893-2896
126. Wang, Y.; Yang, B.; Zhai, Y.; Yin, Z.; Sun, Y.; Rao, Z. Peptidyl aldehyde NK-1.8 k suppresses enterovirus 71 and enterovirus 68 infection by targeting protease 3C. Antimicrob. Agents Chemother. 2015, 59, 2636-2646
127. Liu, S.; Hanzlik, R.P. Structure-activity relationships for inhibition of papain by peptide Michael acceptors. J. Med. Chem. 1992, 35, 1067-1075
128. Kong, J.S.; Venkatraman, S.; Furness, K.; Nimkar, S.; Shepherd, T.A.; Wang, Q.M.; Aubé, J.; Hanzlik, R.P. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication. J. Med. Chem. 1998, 41, 2579-2587
129. Dragovich, P.S.; Webber, S.E.; Babine, R.E.; Fuhrman, S.A.; Patick, A.K.; Matthews, D.A.; Lee, C.A.; Reich, S.H.; Prins, T.J.; Marakovits, J.T.; et al. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Michael acceptor structure-activity studies. J. Med. Chem. 1998, 41, 2806-2818
130. Patick, A.K.; Binford, S.L.; Brothers, M.A.; Jackson, R.L.; Ford, C.E.; Diem, M.D.; Maldonado, F.; Dragovich, P.S.; Zhou, R.; Prins, T.J.; et al. In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob. Agents Chemother. 1999, 43, 2444-2450
131. Tan, J.; George, S.; Kusov, Y.; Perbandt, M.; Anemüller, S.; Mesters, J.R.; Norder, H.; Coutard, B.; Lacroix, C.; Leyssen, P.; et al. 3C protease of enterovirus 68: Structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses. J. Virol. 2013, 87, 4339-4351
132. Van der Linden, L.; Ulferts, R.; Nabuurs, S.B.; Kusov, Y.; Liu, H.; George, S.; Lacroix, C.; Goris, N.; Lefebvre, D.; Lanke, K.H.; et al. Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteases. Antivir. Res. 2014, 103, 17-24
133. Debing, Y.; Kaplan, G.G.; Neyts, J.; Jochmans, D. Rapid and convenient assays to assess potential inhibitory activity on in vitro hepatitis A replication. Antivir. Res. 2013, 98, 325-331
134. De Palma, A.M.; Pürstinger, G.; Wimmer, E.; Patick, A.K.; Andries, K.; Rombaut, B.; de Clercq, E.; Neyts, J. Potential use of antiviral agents in polio eradication. Emerg. Infect. Dis. 2008, 14, 545-551
135. Baxter, A.; Chambers, M.; Edfeldt, F.; Edman, K.; Freeman, A.; Johansson, C.; King, S.; Morley, A.; Petersen, J.; Rawlins, P.; et al. Non-covalent inhibitors of rhinovirus 3C protease. Bioorg. Med. Chem. Lett. 2011, 21, 777-780
136. Kim, B.K.; Cho, J.H.; Jeong, P.; Lee, Y.; Lim, J.J.; Park, K.R.; Eom, S.H.; Kim, Y.C. Benserazide, the first allosteric inhibitor of Coxsackievirus B3 3C protease. FEBS Lett. 2015, 589, 1795-1801
137. Lim, B.K.; Yun, S.H.; Ju, E.S.; Kim, B.K.; Lee, Y.J.; Yoo, D.K.; Kim, Y.C.; Jeon, E.S. Soluble Coxsackievirus B3 3C protease inhibitor prevents cardiomyopathy in an experimental chronic myocarditis murine model. Virus Res. 2015, 199, 1-8
138. Kim, B.K.; Kim, J.H.; Kim, N.R.; Lee, W.G.; Lee, S.D.; Yun, S.H.; Jeon, E.S.; Kim, Y.C. Development of anti-coxsackievirus agents targeting 3C protease. Bioorg. Med. Chem. Lett. 2012, 22, 6952-6956
139. Zhai, Y.; Zhao, X.; Cui, Z.; Wang, M.; Wang, Y.; Li, L.; Sun, Q.; Yang, X.; Zeng, D.; Liu, Y.; et al. Cyanohydrin as an Anchoring Group for potent and selective inhibitors of enterovirus 71 3C protease. J. Med. Chem. 2015, 58, 9414-9420
140. Ramajayam, R.; Tan, K.P.; Liang, P.H. Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery. Biochem. Soc. Trans. 2011, 39, 1371-1375
141. Shie, J.J.; Fang, J.M.; Kuo, T.H.; Kuo, C.J.; Liang, P.H.; Huang, H.J.; Wu, Y.T.; Jan, J.T.; Cheng, Y.S.; Wong, C.H. Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic α, β-unsaturated esters. Bioorg. Med. Chem. 2005, 13, 5240-5252
142. Yang, S.; Chen, S.J.; Hsu, M.F.; Wu, J.D.; Tseng, C.T.; Liu, Y.F.; Chen, H.C.; Kuo, C.W.; Wu, C.S.; Chang, L.W.; et al. Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor. J. Med. Chem. 2006, 49, 4971-4980
143. Kuo, C.J.; Liu, H.G.; Lo, Y.K.; Seong, C.M.; Lee, K.I.; Jung, Y.S.; Liang, P.H. Individual and common inhibitors of coronavirus and picornavirus main proteases. FEBS Lett. 2009, 583, 549-555
144. Prior, A.M.; Kim, Y.; Weerasekara, S.; Moroze, M.; Alliston, K.R.; Uy, R.A.; Groutas, W.C.; Chang, K.O.; Hua, D.H. Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors. Bioorg. Med. Chem. Lett. 2013, 23, 6317-6320
145. Mandadapu, S.R.; Weerawarna, P.M.; Prior, A.M.; Uy, R.A.; Aravapalli, S.; Alliston, K.R.; Lushington, G.H.; Kim, Y.; Hua, D.H.; Chang, K.O.; et al. Macrocyclic inhibitors of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus. Bioorg. Med. Chem. Lett. 2013, 23, 3709-3712
146. Singh, S.B.; Cordingley, M.G.; Ball, R.G.; Smith, J.L.; Dombrowski, A.W.; Goetz, M.A. Structure of stereochemistry of thysanone: A novel human rhinovirus 3C-protease inhibitor from Thysanophora penicilloides. Tetrahedron Lett. 1991, 32, 5279-5282
147. Schünemann, K.; Furkert, D.P.; Choi, E.C.; Connelly, S.; Fraser, J.D.; Sperry, J.; Brimble, M.A. Synthesis of the 2-methylene analogue of the HRV 3C protease inhibitor thysanone (2-carbathysanone). Org. Biomol. Chem. 2014, 12, 905-912
148. Young Jeong, J.; Sperry, J.; Taylor, J.A.; Brimble, M.A. Synthesis and evaluation of 9-deoxy analogues of (´)-thysanone, an inhibitor of HRV 3C protease. Eur. J. Med. Chem. 2014, 87, 220-227
149. Lin, Y.J.; Chang, Y.C.; Hsiao, N.W.; Hsieh, J.L.; Wang, C.Y.; Kung, S.H.; Tsai, F.J.; Lan, Y.C.; Lin, C.W. Fisetin and rutin as 3C protease inhibitors of enterovirus A71. J. Virol. Methods 2012, 182, 93-98
150. Chen, Y.H.; Du, W.; Hagemeijer, M.C.; Takvorian, P.M.; Pau, C.; Cali, A.; Brantner, C.A.; Stempinski, E.S.; Connelly, P.S.; Ma, H.C.; et al. Phosphatidylserine vesicles enable efficient en Bloc transmission of enteroviruses. Cell 2015, 160, 619-630
151. Roosien, J.; Belsham, G.J.; Ryan, M.D.; King, A.M.; Vlak, J.M. Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors. J. Gen. Virol. 1990, 71, 1703-1711